Arteriovenous fistula (AVF) is recommended as the ideal vascular access for hemodialysis (HD), however, there are conflicting opinions when it comes to patients with diabetes mellitus (DM). The aim of the paper was to determine the predictive parameters of AVF maturation for HD in patients with DM. The investigation was organized as a retrospective, descriptive-analytical study. The target group of our research involved 209 patients with DM, in whom AVF was created for HD. We recorded demographic and gender characteristics, location and type of AVF at the time of creation, type of anastomosis, data on the initial (a)function of the fistula, HD catheter placement, and blood pressure. Before the operation, Doppler ultrasound of the blood vessels was performed, and intraoperatively, the lumen of the artery and vein used to form the AVF was measured. We analyzed laboratory variables that were routinely controlled in our institution. Diabetics with successful maturing fistula significantly more often had proximally located AVF (p = 0.004), end-to-side anastomosis type (p = 0.036), and initial function (p = 0.001). In a univariate analysis, the brachiocephalic location of AVF (p = 0.004), end-to-side type of anastomosis (p = 0.039), and initial function of AVF (p = 0.001) were the predictive parameters of AVF maturation. Multivariable statistical analysis showed that brachiocephalic localization of AVF (p=0.021), end-to-side anastomosis type (p = 0.004), and initial function of AVF (p = 0.001) are the predictive parameters of AVF maturation in diabetics. Predictive parameters of fistula maturation, in patients with DM in our study, are the initial function of AVF, brachiocephalic location, and end-to-side anastomosis.
References
1.
Yap YS, Chi WC, Lin CH, Liu YC, Wu YW. Association of early failure of arteriovenous fistula with mortality in hemodialysis patients. Scientific Reports. 11(1).
2.
Konner K, Lomonte C, Basile C. Placing a primary arteriovenous fistula that works—more or less known aspects, new ideas. Nephrology Dialysis Transplantation. 2013;28(4):781–4.
3.
Brzychczy A, Lejman W, Walatek B. The influence of some qualitative and quantitative factors on the functioning of the arteriovenous fistula for a period longer than 24 months [Article in Polish. Nefrol Dial Pol. 2006;10:12–6.
4.
ElKassaby M, Elsayed N, Mosaad A, Soliman M. End-to-side versus side-to-side anastomosis with distal vein ligation for arteriovenous fistula creation. Vascular. 2021;29(5):790–6.
5.
Janeckova J, Bachleda P, Utikal P. Evaluating the effectiveness of arterio venous fistula creation strategy in diabetics. Clin Surg. 2018;3(2132).
6.
Farrington CA, Robbin ML, Lee T, Barker-Finkel J, Allon M. Early Predictors of Arteriovenous Fistula Maturation: A Novel Perspective on an Enduring Problem. Journal of the American Society of Nephrology. 2020;31(7):1617–27.
7.
Hentschel DM. Determinants of Arteriovenous Fistula Maturation. Clinical Journal of the American Society of Nephrology. 2018;13(9):1307–8.
8.
Rooijens PPGM, Tordoir JHM, Stijnen T, Burgmans JPJ, Smet de AAEA, Yo TI. Radiocephalic Wrist Arteriovenous Fistula for Hemodialysis: Meta-analysis Indicates a High Primary Failure Rate. European Journal of Vascular and Endovascular Surgery. 2004;28(6):583–9.
9.
Lee T, Mokrzycki M, Moist L, Maya I, Vazquez M, Lok CE, et al. Standardized Definitions for Hemodialysis Vascular Access. Seminars in Dialysis. 2011;24(5):515–24.
10.
Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: Comparison between patients with and without diabetes. American Journal of Kidney Diseases. 2001;38(3):560–4.
11.
Salmela B, Hartman J, Peltonen S, Albäck A, Lassila R. Thrombophilia and Arteriovenous Fistula Survival in ESRD. Clinical Journal of the American Society of Nephrology. 2013;8(6):962–8.
12.
Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. Journal of Vascular Surgery. 2011;54(5):1383–9.
13.
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402(10397):203–34.
14.
Nur Keser B. Hemoglobin A1c levels do not predict primary arteriovenous fistula failure in hemodialysis patients. Cardiovascular Surgery and Interventions. 8(3):139–44.
15.
Ullah S, Imtiaz N, Ullah S, Arshad AR. Comparison of Primary Failure Rates for Radiocephalic, Brachiocephalic and Brachiobasilic Fistulas Between Patients of Diabetes and Non-Diabetes with Chronic Kidney Disease. Pakistan Armed Forces Medical Journal. 74(2):415–9.
16.
Sabiu G, Gallieni M. Pathophysiology of Arteriovenous Fistula Maturation and Nonmaturation. Clinical Journal of the American Society of Nephrology. 2023;18(1):8–10.
17.
Jeong S, Kwon H, Chang JW, Kim MJ, Ganbold K, Han Y, et al. Comparison of outcomes between type 2 diabetic and non-diabetic incident hemodialysis patients with functioning arteriovenous fistulas. Medicine. 98(48):e18216.
18.
Bashar K, Zafar A, Elsheikh S, Healy DA, Clarke-Moloney M, Casserly L, et al. Predictive Parameters of Arteriovenous Fistula Functional Maturation in a Population of Patients with End-Stage Renal Disease. PLOS ONE. 10(3):e0119958.
19.
Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, et al. Objectives and Design of the Hemodialysis Fistula Maturation Study. American Journal of Kidney Diseases. 2014;63(1):104–12.
20.
Stolic R. Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis. Medical Principles and Practice. 2013;22(3):220–8.
21.
Gordon AC, Dholakia S, Ashby D, Crane JS. Diabetes should not dissuade arteriovenous fistula formation. British Journal of Diabetes. 16(3):119.
22.
Yan Y, Ye D, Yang L, Ye W, Zhan D, Zhang L, et al. A meta-analysis of the association between diabetic patients and AVF failure in dialysis. Renal Failure. 2018;40(1):379–83.
23.
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases. 2020;75(4):S1–164.
24.
Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017;55(1):66–76.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
